Effectiveness of methotrexate as a second-line treatment for cardiac sarcoidosis assessed via 18 F-FDG PET: a case report.

Published in: European heart journal. Case reports (2022)

Methotrexate may have a direct anti-inflammatory effect in patients with CS refractory to regular corticosteroid therapy.

Keyphrases